2023 ESC Guidelines for the management of endocarditis: Developed by the task force on the management of endocarditis of the European Society of Cardiology …

V Delgado, N Ajmone Marsan, S de Waha… - European heart …, 2023 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

[HTML][HTML] Clinical Outcomes of Rifampicin Combination Therapy in Implant-Associated Infections due to Staphylococci and Streptococci: A Systematic Review and Meta …

E Yusuf, W Bramer, AA Anas - International Journal of Antimicrobial Agents, 2023 - Elsevier
Aim of study Adjunctive rifampicin for implant associated infections (IAI) is controversial. We
investigated the clinical outcomes of rifampicin combination therapy in comparison to …

Endocarditis after transcatheter aortic valve replacement

L Braghieri, S Kaur, CK Black, PC Cremer… - Journal of Clinical …, 2023 - mdpi.com
Transcatheter aortic valve replacement (TAVR) use is gaining momentum as the mainstay
for the treatment of aortic stenosis compared to surgical aortic valve replacement (SAVR) …

World Workshop on Oral Medicine VIII: Dentists' compliance with infective endocarditis prophylaxis guidelines for patients with high-risk cardiac conditions: a …

PD Dios, L Monteiro, K Pimolbutr, M Gobbo… - Oral Surgery, Oral …, 2023 - Elsevier
Objective To determine dentists' awareness and/or adherence to antibiotic prophylaxis (AP)
guidelines for preventing infective endocarditis (IE) in patients with high-risk heart …

Impact of Enterococci vs. Staphylococci Induced Infective Endocarditis after Transcatheter Aortic Valve Implantation

T Gasior, FJ Woitek, A Schroth, M Abdel-Wahab… - Journal of Clinical …, 2023 - mdpi.com
Background: The two most common organisms found in infective endocarditis following
transcatheter aortic valve implantation (TAVI-IE) are enterococci (EC-IE) and staphylococci …

[PDF][PDF] 2023 ESC Guidelines for the management of endocarditis

NA Marsan, S de Waha, N Bonaros, S Caselli… - European Heart …, 2023 - isoic.org
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia in a Patient With Multiple Cardiovascular Disease Risk Factors

S Kelly, T Randolph, C Cardy - The Journal for Nurse Practitioners, 2024 - Elsevier
We present a case report of a 75-year-old man with multiple cardiovascular disease risk
factors and a past surgical history of bioprosthetic aortic valve replacement who presented to …

Инфекционный эндокардит: осложнения, особенности течения у различных групп населения, лечение, профилактика. Обзор литературы

ОН Жданова, ОА Беркович… - Новые Санкт …, 2024 - spbmedicalrecords.elpub.ru
Аннотация В литературном обзоре представлен анализ отечественных и зарубежных
публикаций, современных клинических рекомендаций по инфекционному эндокардиту …

[PDF][PDF] Infective endocarditis in the transcatheter era

S Saha - 2024 - edoc.ub.uni-muenchen.de
1.1 Background Transcatheter aortic valve replacement (TAVR) has come a long way since
the first described case in 2002 by Cribier et al.[1] in a multimorbid patient in cardiogenic …

Infektiöse Endokarditis

S Saha, P Schnackenburg, S Sadoni, D Joskowiak… - Die Kardiologie, 2022 - Springer
Die infektiöse Endokarditis (IE) ist eine meist bakteriell verursachte hochkomplexe
Multisystemerkrankung kardiovaskulärer Strukturen, die trotz technologischer Fortschritte in …